• OPEN AN ACCOUNT
Indian Indices
Sensex
78,581.00 152.05
( 0.19%)
Global Indices
Nasdaq
54,113.09 913.68
(1.72%)
Dow Jones
7,758.57 137.07
(1.80%)
Hang Seng
66,265.57 2,308.04
(3.61%)
Nikkei 225
10,894.52 15.14
(0.14%)
Forex
USD-INR
95.29 -0.10
(-0.11%)
EUR-INR
109.78 -0.22
(-0.20%)
GBP-INR
128.18 -0.43
(-0.33%)
JPY-INR
0.61 0.00
(0.31%)

EQUITY - MARKET SCREENER

Acutaas Chemicals Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs
BSE Code
ISIN Demat
Book Value()
543349
INE00FF01025
203.7819344
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
ACUTAAS
66.32
26354.31
EPS(TTM)
Face Value()
Div & Yield %
48.54
5
0.08
 

Arfin India consolidated net profit rises 1186.79% in the March 2026 quarter
May 11,2026
Net profit of Arfin India rose 1186.79% to Rs 6.82 crore in the quarter ended March 2026 as against Rs 0.53 crore during the previous quarter ended March 2025. Sales rose 26.00% to Rs 193.24 crore in the quarter ended March 2026 as against Rs 153.37 crore during the previous quarter ended March 2025.

For the full year,net profit rose 68.85% to Rs 15.45 crore in the year ended March 2026 as against Rs 9.15 crore during the previous year ended March 2025. Sales rose 0.36% to Rs 617.99 crore in the year ended March 2026 as against Rs 615.75 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales193.24153.37 26 617.99615.75 0
OPM %8.454.30 -7.475.90 -
PBDT12.173.29 270 28.3518.44 54
PBT10.832.27 377 23.7114.38 65
NP6.820.53 1187 15.459.15 69